Tri-Membrane Wrap Developed to Protect
Deep Wounds in Difficult-to-Cover Areas
PHOENIX, Oct. 2, 2024
/PRNewswire/ -- BioLab Holdings, Inc.'s skin substitute brand,
BioLab Sciences, a Phoenix-based
medical manufacturer specializing in wound healing and wound care
products, announced today the launch of its newest amniotic
membrane tissue product, the Tri-Membrane Wrap. The wrap became
officially available through Medicare effective Oct. 1.
The Tri-Membrane Wrap is a more robust skin
substitute developed to protect deep wounds and poorly located
areas.
The Tri-Membrane Wrap is a more robust skin substitute developed
to protect deep wounds and poorly located areas. Its triple-layer
design of dehydrated Amnion-Chorion-Amnion tissue increases its
thickness, improving its tensile strength, allowing for suturing as
needed. This product provides more membrane than other skin
substitute options and is ideal for more extensive wounds over
which a wound VAC system could be placed. It is available in
multiple sizes ranging from 4-square-centimeters to
480-square-centimeters.
"This is the fourth product added to our family of amniotic
products," said Chief Medical Officer Dr. Marshall Medley. "Part of our mission is to
provide clinicians more wound care options, so they can choose the
best product for the for their patients' unique needs. We aim to
continually bring new, innovative skin substitutes to the field and
assist providers with refractory wounds."
The Tri-Membrane Wrap is Tissue Reference Group (TRG) registered
with the FDA. The product has a dedicated HCPCS code – Q4334. It
will be available through three prominent Medicare Administrative
Contractor (MAC) jurisdictions – FCSO, NOVITAS and CGS.
In addition to its top-of-the-line wound care products, BioLab
strives to set itself apart through its extensive suite of services
designed to assist providers long before and after its skin
substitutes are applied to a patient. Prior to supplying its
products to a new provider, BioLab offers support with product
protocols and timeline guidance, application training, benefit and
insurance verifications, billing training and product inservice
education. Post-application, the BioLab team continues to assist
with proof-of-concept guidance, billing services, denied claims
support and charity care services.
Providers and distributors wanting to learn more can meet BioLab
Sciences representatives at the Symposium on Advanced Wound Care
Oct. 2-5 in Las Vegas at booth 245. For more information
on BioLab Holdings, Inc. and its products, visit
biolabholdings.net.
About BioLab Holdings, Inc.
BioLab
Holdings, Inc. is a Phoenix-based medical manufacturer
specializing in wound healing. Its products, Membrane Wrap
Lite™, Tri-Membrane Wrap™, Membrane
Wrap™, and Membrane Wrap - Hydro™, use human
tissue allograft derived from amniotic membrane that provides
structural tissue for use as a wound protectant covering. The
products are minimally manipulated, preserving the properties that
the tissue exhibits in its natural state. The company's mission is
to manufacture reliable and safe products with the highest quality
to help optimize body performance through continuous innovation,
education, superior customer service and teamwork. For more
information, visit biolabholdings.net.
Media contact: Kwyn Lowe,
kwyn@evolveprandmarketing.com
View original
content:https://www.prnewswire.com/news-releases/biolab-holdings-inc-launches-new-triple-layered-amniotic-skin-substitute-product-302266026.html
SOURCE BioLab Sciences